Effects of the N-methyl-D-aspartate receptor blocker MK-801 on neurologic function after experimental brain injury.
Effects of the N-methyl-D-aspartate receptor blocker MK-801 on neurologic function after experimental brain injury.
复制标题
N-甲基-D-天冬氨酸受体阻滞剂 MK-801 对实验性脑损伤后神经功能的影响。
DOI:
10.1089/neu.1989.6.247
复制
发表时间:
1989
影响因子:
4.2
通讯作者:
Simon,R
中科院分区:
文献类型:
--
作者:
Mcintosh,TK;Vink,R;Soares,H;Hayes,R;Simon,R
Pharmacologic inhibition of excitatory amino acid (EAA) neurotransmission attenuates cell death in models of global and focal ischemia and hypoglycemia and improves neurologic outcome after experimental traumatic spinal cord injury. The present study examined the effects of the noncompetitiveN-methyl-d-aspartate (NMDA) receptor blocker MK-801 on cardiovascular and neurologic function after experimental fluid-percussion (FP) brain injury in the rat. Animals received either an intravenous bolus of MK-801 (1 mg/kg) or saline (equal volume) 15 min prior to FP brain injury or 15 min following FP brain injury. MK-801 pretreatment significantly improved postinjury cardiovascular variables and attenuated postinjury neurologic dysfunction. Postinjury treatment with MK-801 also significantly improved cardiovascular variables, but had little effect on postinjury neurologic scores. These results suggest that EAA neurotransmitters may be involved in the pathophysiological sequelae of traumatic brain injury and that noncompetitive blockade of the NMDA receptor prior to brain injury may reduce EAA-induced damage and limit neurologic dysfunction.